| Financial Year |
March 31 2023 |
| Monetary Funds |
533,837,578.42 |
| Held-for-trading Financial Assets |
105,667,220.96 |
| Notes Receivable |
14,929,610.21 |
| Accounts Receivable |
106,347,886.32 |
| Advances to Suppliers |
29,322,685.74 |
| Other Receivables |
167,354,816.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
27,284,293.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
994,630,694.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
324,925,264.80 |
| Investment Properties |
1,385,925.96 |
| Fixed Assetes |
291,561,621.96 |
| Under-construction Projects |
196,004,368.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,335,419.19 |
| R&D expenses |
14,792,293.28 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,129,375.88 |
| Deferred Income Tax Assets |
25,699,893.61 |
| Other Non-Current Assets |
34,961,388.00 |
| Sub-Total of Non-Current Assets |
1,025,523,588.28 |
| Total Assets |
2,020,154,282.80 |
| Short-Term Loans |
99,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,746,509.52 |
| Accounts Payable |
18,336,810.80 |
| Accounts Received In Advance |
36,749.51 |
| Employee Compensation Payable |
5,964,452.35 |
| Taxes Payable |
7,011,163.53 |
| Interest Payable |
-- |
| Dividend Payable |
392,600.00 |
| Other payables |
164,741,038.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,149,112.33 |
| Other Current Liabilities |
8,805,536.20 |
| Sub-Total of Current Liabilities |
314,097,184.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,937.72 |
| Deferred Income Tax Liabilities |
5,473,117.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,610,778.98 |
| Total Liabilities |
331,707,963.88 |
| Paid-In Capital(Or Share Stock) |
373,270,285.00 |
| Capital Surplus |
821,345,676.32 |
| Surplus Reserve |
124,268,347.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
485,616,731.88 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,688,446,318.92 |
| Owner's Equity（Stockholder's Equity） |
1,688,446,318.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,020,154,282.80 |
